CASE REPORT
COVID-19 infection as a trigger for the manifestation of celiac disease in a 4-year-old child
 
More details
Hide details
1
Clinical Department of Paediatrics in Strzelce Opolskie, Institute of Medical Sciences, University of Opole, Opole, Poland
 
2
Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland
 
 
Submission date: 2023-02-11
 
 
Final revision date: 2023-04-18
 
 
Acceptance date: 2023-04-22
 
 
Publication date: 2023-09-25
 
 
Corresponding author
Anna Jarzumbek
Anna Jarzumbek, MD, PhD, Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland
 
 
Pediatr Pol 2023;98(3):267-270
 
KEYWORDS
TOPICS
ABSTRACT
The article presents the case of a girl who, after being infected with COVID-19, developed a seroconversion of anti-tissue transglutaminase antibodies as she developed symptoms from the gastrointestinal tract, which consequently allowed her to be diagnosed with celiac disease. In recent years, more and more articles describing possible autoimmune complications have been published after suffering from an infection caused by the SARS-CoV-2 virus. The aim of the work was to show how many diseases are potentially related to COVID-19 infection, pointing out that in the medical literature, the number of articles describing such cases in the paediatric population is still insufficient. We describe herein the case of a 4-year-old patient, who was diagnosed with celiac disease after suffering from COVID-19. We also aim to return attention to vigilantly observing any new symptoms that appear from various source organs after suffering an infection caused by the SARS-CoV-2 virus.
REFERENCES (18)
1.
Trovato CM, Montuori M, Pietropaoli N, Oliva S. COVID-19 and celiac disease: a pathogenetic hypothesis for a celiac outbreak. Int J Clin Pract 2021; 75: e14452.
 
2.
Cakir M, Guven B, Issi F et al. New-onset celiac disease in children during COVID-19 pandemic. Acta Paediatr 2022; 111: 383-388.
 
3.
Socha P, Lebensztejn D, Kamińska D. Gastroenterologia dziecięca – podręcznik do specjalizacji. Wydawnictwo Media-Press Sp. z o.o, Warszawa 2016, 27-33.
 
4.
Husby S, Koletzko S, Korponay-Szabo I, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for diagnosing coeliac disease 2020. J Ped Gastroenterol Nutr 2020; 70: 141-156.
 
6.
Samasca G, Lerner A. Celiac disease in the COVID-19 pandemic. J Translat Autoimm 2021; 4: 100120.
 
7.
Greco N, Meacci A, Mora B, et al. Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect? Ann Med 2022; 54: 617-621.
 
8.
Mobasheri L, Nasirpour MH, Masoumi E, et al. SARS-CoV-2 triggering autoimmune diseases. Cytokine 2022; 154: 155873.
 
9.
Jesenak M, Brndiarova M, Urbancikova I, et al. Immune parameters and COVID-19 infection-associations with clinical severity and diseases prognosis. Front Cell Infect Microbiol 2020; 10: 364.
 
10.
Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res 2020; 68: 310-313.
 
11.
Kanduc D. From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies 2020; 9: 33.
 
12.
Ji-Young S. Pediatric endocrinology of post-pandemic era. Chonnam Med J 2021; 57: 103-107.
 
13.
Kay G, Cimbek EA, Yesilbaş O, et al. A long-term comparison of presenting characteristics of children with newly diagnosed type 1 diabetes before and during the COVID-19 pandemic. J Clin Res Pediatr Endocrinol 2022; 14: 267-274.
 
14.
Sakaleshpur Kumar V, Dhananjaya SR, Sathish HS, et al. Auto-immune thyroiditis in SARS-CoV-2 exposed twins. Eur Rev Med Pharmacol Sci 2022; 26: 4881-4883.
 
15.
Dabas A, Singh H, Goswami B, et al. Thyroid dysfunction in COVID-19. Indian J Endocrinol Metab 2021; 25: 198-201.
 
16.
Harris A, Al Mushref M. Graves’ thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep 2021; 7: 14-16.
 
17.
Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol 2022; 94: 54-62.
 
18.
Erard D, Villeret F, Lavrut PM, et al. Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty? Clin Res Hepatol Gastroenterol 2022; 46: 101841.
 
Journals System - logo
Scroll to top